Portal Biotechnologies

About Portal Biotechnologies

Portal Biotechnologies is focused on next-generation cell engineering and drug discovery, providing innovative solutions for intracellular delivery critical to research and clinical applications. Their mission is to power workflows at every scale with award-winning platforms for cell therapy and regenerative medicine.

Products & Services

Gateway:Proprietary instruments and consumables for R&D scale cell engineering.

Galaxy - NEW!:High throughput integrations for modifying existing workflows to be Powered by Portal™.

Millibooster - NEW!:Clinical scale integrations with consumables compatible with common manufacturing equipment.

Point-of-Care System Integrations:Enables same-day production of autologous therapeutic cells at the patient point-of-care/bedside.

Specialties

Cell Engineering Drug Discovery Intracellular Delivery Gene Editing Cell Therapies Regenerative Medicine Immunotherapies Hit Identification Assay Reagent Delivery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 7000000 MR: - FA: $7M FAN: 7000000	D: 2024-12-19 FD: 2024-12-19	6 investors
2	RT: Pre-Seed T: - FT: Pre-Seed	A: 5000000 MR: - FA: $5M FAN: 5000000	D: 2024-03-19 FD: 2024-03-19	3 investors

Seed Latest

2024-12-19

$7.0M

6 investors (Pro only)

Pre-Seed 2024-03-19

$5.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Armon Sharei

Founder and CEO

A

Alec Barclay

Co-Founder & COO

A

Anil Narasimha

Head of Strategic Partnerships

A

Andressa Carroll

Director, People & Culture

C

Carolyn Corbet

Applications Partner

C

Courtney Dysthe

Scientific Partner

View 19 more team members with Pro

Unlock Full Team Directory

Recent News